Intensity Therapeutics

(NASDAQ) INTS

Current Price$3.69

Market Cap$9.78M

Since IPO (2023)-98%

5 YearN/A

1 Year-55%

1 Month-24%

Intensity Therapeutics Financials at a Glance

Market Cap

$9.78M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.69M

EPS (TTM)

-$7.08

P/E Ratio

-0.51

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.69

Volume

26,029.302

Open

$3.70

Price

$3.69

Volume

26,029.302

Open

$3.70

Previous Close

$3.62

Daily Range

$3.60 - $3.75

52-Week Range

$3.51 - $43.50

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.69

Volume

26,029.302

Open

$3.70

Previous Close

$3.62

Daily Range

$3.60 - $3.75

52-Week Range

$3.51 - $43.50

Estimated Earnings Date

Aug 6, 2026

INTS News

Intensity (INTS) Q2 Net Loss Drops 50%

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intensity Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Lewis H. Bender, MBA

Website

www.intensitytherapeutics.com

Headquarters

Westport, CT 06880, US

INTS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-207%

Return on Capital

-1%

Return on Assets

-87%

Earnings Yield

-1.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.78M

Shares Outstanding

2.70M

Volume

26.03K

Avg. Volume

28.45K

Financials (TTM)

Gross Profit

-$26.00K

Operating Income

-$11.97M

EBITDA

-$11.61M

Operating Cash Flow

-$9.23M

Capital Expenditure

$0.00

Free Cash Flow

-$9.23M

Cash & ST Invst.

$11.92M

Total Debt

$110.00K

Intensity Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$7.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.78M

N/A

Market Cap/Employee

$1.96M

N/A

Employees

N/A

Net Income

-$2.43M

+27.3%

EBITDA

-$2.43M

+27.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$10.25M

+1002.8%

Total Debt

$102.00K

-22.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$70.00K

-31.4%

Short Term Debt

$32.00K

+10.3%

Return on Assets

-87.00%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

-$1.83M

+8.2%

Operating Cash Flow

-$1.83M

+8.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$5.01-7.56%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$2.08-6.95%

ITRMIterum Therapeutics plc

ITRMIterum Therapeutics plc$0.03-10.98%

PLURPluri Inc.

PLURPluri Inc.$2.27+0.89%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.69+1.20%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.41+1.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About INTS

What is the current price of Intensity Therapeutics?

Intensity Therapeutics is trading at $3.62 per share.

What is the 52-week range for Intensity Therapeutics?

Over the past 52 weeks, Intensity Therapeutics has traded between $3.51 and $43.50.

How much debt does Intensity Therapeutics have?

As of the most recent reporting period, Intensity Therapeutics reported total debt of $102.00K.

How much cash does Intensity Therapeutics have on hand?

Intensity Therapeutics reported $10.25M in cash and cash equivalents in its most recent financial results.

What is Intensity Therapeutics’s dividend yield?

Intensity Therapeutics does not currently have a dividend yield.

Intensity Therapeutics

Intensity Therapeutics Financials at a Glance

INTS News

Intensity (INTS) Q2 Net Loss Drops 50%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Intensity Therapeutics

INTS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Intensity Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INTS

What is the current price of Intensity Therapeutics?

What is the 52-week range for Intensity Therapeutics?

How much debt does Intensity Therapeutics have?

How much cash does Intensity Therapeutics have on hand?

What is Intensity Therapeutics’s dividend yield?

Premium Investing Services